Original Research
Published on 12 Nov 2021
Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors
in Surgical Oncology
- 2,920 views
- 14 citations
Original Research
Published on 12 Nov 2021
in Surgical Oncology
Original Research
Published on 12 Nov 2021
in Surgical Oncology
Systematic Review
Published on 11 Nov 2021
in Surgical Oncology
Original Research
Published on 11 Nov 2021
in Surgical Oncology
Systematic Review
Published on 10 Nov 2021
in Surgical Oncology
Original Research
Published on 09 Nov 2021
in Surgical Oncology
Original Research
Published on 08 Nov 2021
in Surgical Oncology
Original Research
Published on 05 Nov 2021
in Surgical Oncology
Original Research
Published on 05 Nov 2021
in Surgical Oncology
Case Report
Published on 05 Nov 2021
in Surgical Oncology
Original Research
Published on 04 Nov 2021
in Surgical Oncology
Original Research
Published on 01 Nov 2021
in Surgical Oncology
Original Research
Published on 28 Oct 2021
in Surgical Oncology
Original Research
Published on 27 Oct 2021
in Surgical Oncology
Systematic Review
Published on 27 Oct 2021
in Surgical Oncology
Original Research
Published on 27 Oct 2021
in Surgical Oncology